Olympus
Olympus is passionate about creating customer-driven solutions for the medical industry.
Launch date
Employees
Market cap
€20.4b
Enterprise valuation
€19.9b (Public information from Sep 2024)
Share price
JPY2646 7733.T
Tokyo Japan (HQ)
Financials
Estimates*
JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 730.5b | 868.9b | 881.9b | 936.2b | 1.0t | 1.1t | 1.1t |
% growth | (8 %) | 19 % | 2 % | 6 % | 7 % | 5 % | 6 % |
EBITDA | 143.1b | 219.9b | 257.2b | 112.1b | 235.7b | 270.6b | 290.6b |
% EBITDA margin | 20 % | 25 % | 29 % | 12 % | 23 % | 26 % | 26 % |
Profit | 12.9b | 115.7b | 143.4b | 242.6b | 116.8b | 140.7b | 156.8b |
% profit margin | 2 % | 13 % | 16 % | 26 % | 12 % | 13 % | 14 % |
EV / revenue | 4.2x | 3.5x | 3.5x | 2.7x | 3.1x | 2.8x | 2.6x |
EV / EBITDA | 21.5x | 13.9x | 12.0x | 22.6x | 13.1x | 10.9x | 10.0x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | $600m | Post IPO Equity | |
Total Funding | - |